Lexicon Pharmaceuticals (LXRX) Preferred Shares (2024 - 2026)

Lexicon Pharmaceuticals (LXRX) reported Preferred Shares of $4000.0 for Q1 2026, down 82.61% quarter-over-quarter from $23000.0 in Q1 2024.

Lexicon Pharmaceuticals (LXRX) Preferred Shares (2024 - 2026) Analysis & Trends

Lexicon Pharmaceuticals (LXRX) has 2 years of Preferred Shares data on file, last reported at $4000.0 in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Lexicon Pharmaceuticals 804.48 Mn 633.82 Mn 20.99 Mn 4,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 4,000.00
Mar 31, 2024 23,000.00